Form 8-K - Current report:
SEC Accession No. 0001213900-26-003480
Filing Date
2026-01-12
Accepted
2026-01-12 16:59:37
Documents
13
Period of Report
2026-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0272498-8k_pmgchold.htm   iXBRL 8-K 35229
2 FORM OF PRE-PAID PURCHASE # 2 ea027249801ex10-1_pmgchold.htm EX-10.1 56636
  Complete submission text file 0001213900-26-003480.txt   277358

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20260107.xsd EX-101.SCH 3026
4 XBRL LABEL FILE elab-20260107_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE elab-20260107_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0272498-8k_pmgchold_htm.xml XML 3325
Mailing Address 675 WEST HASTINGS STREET SUITE 805 VANCOUVER British Columbia, Canada V6B1N2
Business Address 675 WEST HASTINGS STREET SUITE 805 VANCOUVER British Columbia, Canada V6B1N2 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 26527550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)